A new European Union (EU)-funded project is set to provide accessible and reliable information about cell and gene-based therapies in Scotland. Known as EuroGCT, its…
The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded…
Financing in the regenerative medicine biotech market, especially for those firms developing cell and gene therapies, absolutely explodes as last year global financing for companies…
Cambridge, Massachusetts-based gene therapy venture ElevateBio raised a staggering $525 million Series C financing to continue its pursuit of disruptive medicinal models addressing some of…
Two patients with sickle cell disease involved with a gene-based therapy trial now have been diagnosed with cancer, and the clinical trial that is their…
A gene therapy for patients with transfusion-dependent beta thalassemia (TDT) didn’t fare well after a thorough review by the United Kingdom’s National Institute for Health…
A Philadelphia gene-therapy biotech venture just raised $88 million in investment from Johnson & Johnson and other investors, domestic and from Europe, to help accelerate…
Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announces that it has led a €20 million Series A financing…
A painful inherited blood disorder affecting millions of people, especially Black people, occurs because of a deficiency of red blood cells to actually carry oxygen…
Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has lifted…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
